GT Biopharma, Inc.
Pharmaceutical company · San Francisco, California, United States · Nasdaq: GTBP
GT Biopharma, Inc. is a pharmaceutical company headquartered in San Francisco, California, United States. Its shares trade on Nasdaq under the ticker GTBP. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2025.
GT Biopharma at a glance
What does GT Biopharma do?
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $6 million sold (2025).
Frequently asked questions about GT Biopharma
Where is GT Biopharma headquartered?
GT Biopharma, Inc. is headquartered in San Francisco, California, United States.
What does GT Biopharma do?
GT Biopharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is GT Biopharma a public company?
Yes. GT Biopharma, Inc. trades on Nasdaq under the ticker GTBP.
Similar companies
- Kyntra Bio, Inc.San Francisco, California, United States
- Nektar TherapeuticsSan Francisco, California, United States
- Olema Pharmaceuticals, Inc.San Francisco, California, United States
- Delpor, Inc.San Francisco, California, United States
- Jaguar Health, Inc.San Francisco, California, United States
- Silver Creek Pharmaceuticals, Inc.San Francisco, California, United States
- Amarantus Bioscience Holdings, Inc.San Francisco, California, United States
- Napo Pharmaceuticals IncSan Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences